SCHEMBL7107628

SCHEMBL7107628

CCCCc1ccc(Nc2nc(SC)c3nc[nH]c3n2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLA1 P09884 7/20 0.71
HPGD P15428 3/20 0.46
MAPT P10636 3/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.39
TP53 P04637 2/20 0.39
XBP1 P17861 1/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 2/20 0.37
CASP3 P42574 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10798696 0.83 POLA1 (0.69) POLA1HPGDMAPTNPC1RAB9A
SCHEMBL7107635 0.83 POLA1 (1.00) POLA1HPGDMAPTNPC1RAB9A
SCHEMBL7108860 0.81 POLA1 (0.71) POLA1HPGDMAPTNPC1RAB9A
SCHEMBL17144144 0.76 POLA1 (0.49) POLA1HPGDMAPTNPC1RAB9A
SCHEMBL11012622 0.75 RAB9A (0.55) POLA1HPGDMAPTNPC1RAB9A
SCHEMBL3496869 0.73 POLA1 (0.70) POLA1HPGDMAPTNPC1RAB9A
SCHEMBL10798703 0.71 POLA1 (1.00) POLA1HPGDMAPTNPC1RAB9A
SCHEMBL1264648 0.70 STK17A (0.54) POLA1TP53HSD17B10ALDH1A1STK17A
SCHEMBL1266331 0.70 STK17A (0.54) POLA1TP53HSD17B10ALDH1A1STK17A
SCHEMBL7108861 0.69 POLA1 (1.00) POLA1HPGDMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200435-B1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2003-10-01 EP claimed
US-6589950-B1 Treatment of inflammatory or obstructive airways disease for respiratory system disorders NOVARTIS AG (CH) 2003-07-08 US claimed
EP-1200435-B1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2003-10-01 EP disclosed
US-6589950-B1 Treatment of inflammatory or obstructive airways disease for respiratory system disorders NOVARTIS AG (CH) 2003-07-08 US disclosed
EP-1200435-A1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK Novartis AG (CH) 2002-05-02 EP disclosed
WO-2001009134-A1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2001-02-08 WO disclosed